Camden National Bank Edwards Lifesciences Corp Transaction History

Camden National Bank

$633 Million
Q2 2024

A detailed history of Camden National Bank transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Camden National Bank holds 80,191 shares of EW stock, worth $5.37 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

80,191

Previous 70,346 14.0%

Holding current value

$5.37 Million

Previous $6.72 Million 10.19%

% of portfolio

1.17%

Previous 1.22%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $829,933 - $928,481	9,845 Added 14.0%	80,191 $7.41 Million
Q1 2024 Apr 30, 2024	SELL	$72.54 - $95.56 $37,648 - $49,595	-519 Reduced 0.73%	70,346 $6.72 Million
Q4 2023 Feb 12, 2024	SELL	$61.71 - $77.76 $149,338 - $188,179	-2,420 Reduced 3.3%	70,865 $5.4 Million
Q3 2023 Nov 03, 2023	BUY	$69.28 - $93.38 $10,322 - $13,913	149 Added 0.2%	73,285 $5.08 Million
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $53,160 - $61,597	-653 Reduced 0.88%	73,136 $6.9 Million
Q1 2023 May 08, 2023	BUY	$74.26 - $84.51 $50,348 - $57,297	678 Added 0.93%	73,789 $6.1 Million
Q4 2022 Feb 10, 2023	SELL	$68.3 - $87.44 $156,338 - $200,150	-2,289 Reduced 3.04%	73,111 $5.46 Million
Q3 2022 Nov 04, 2022	BUY	$82.37 - $107.29 $22,816 - $29,719	277 Added 0.37%	75,400 $6.23 Million
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $59,512 - $88,249	688 Added 0.92%	75,123 $7.14 Million
Q1 2022 May 05, 2022	SELL	$101.96 - $128.34 $16,619 - $20,919	-163 Reduced 0.22%	74,435 $8.76 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $113,603 - $139,566	-1,068 Reduced 1.41%	74,598 $9.66 Million
Q3 2021 Nov 09, 2021	SELL	$102.91 - $122.75 $77,285 - $92,185	-751 Reduced 0.98%	75,666 $8.57 Million
Q2 2021 Aug 09, 2021	SELL	$83.84 - $104.76 $130,455 - $163,006	-1,556 Reduced 2.0%	76,417 $7.91 Million
Q1 2021 Aug 04, 2021	BUY	$78.68 - $90.67 $55,784 - $64,285	709 Added 0.92%	77,973 $6.52 Million
Q4 2020 Feb 01, 2021	SELL	$71.69 - $91.23 $152,699 - $194,319	-2,130 Reduced 2.68%	77,264 $7.05 Million
Q3 2020 Nov 05, 2020	BUY	$67.19 - $87.44 $3.24 Million - $4.22 Million	48,274 Added 155.12%	79,394 $6.34 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1.79 Million - $2.39 Million	31,120 New	31,120 $2.15 Million

Others Institutions Holding EW

# of Institutions

1,356

Shares Held

468M

Call Options Held

2.45M

Put Options Held

2.56M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Camden National Bank with notifications on news.

Account

Camden National Bank Edwards Lifesciences Corp Transaction History